These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 11867759

  • 1. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
    de Vries A, Flores ER, Miranda B, Hsieh HM, van Oostrom CT, Sage J, Jacks T.
    Proc Natl Acad Sci U S A; 2002 Mar 05; 99(5):2948-53. PubMed ID: 11867759
    [Abstract] [Full Text] [Related]

  • 2. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.
    Luo JL, Yang Q, Tong WM, Hergenhahn M, Wang ZQ, Hollstein M.
    Oncogene; 2001 Jan 18; 20(3):320-8. PubMed ID: 11313961
    [Abstract] [Full Text] [Related]

  • 3. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A, Resnick MA.
    Oncogene; 2001 Jun 07; 20(26):3409-19. PubMed ID: 11423991
    [Abstract] [Full Text] [Related]

  • 4. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM, Wagner AJ, O'Leary M, Liao S, Hay N.
    Oncogene; 2001 Feb 08; 20(6):659-68. PubMed ID: 11313999
    [Abstract] [Full Text] [Related]

  • 5. Wild-type function of the p53 tumor suppressor protein is not required for apoptosis of mouse hepatoma cells.
    Unger C, Buchmann A, Bünemann CL, Kress S, Schwarz M.
    Cell Death Differ; 1998 Jan 08; 5(1):87-95. PubMed ID: 10200449
    [Abstract] [Full Text] [Related]

  • 6. Mutant p53 protein expression interferes with p53-independent apoptotic pathways.
    Li R, Sutphin PD, Schwartz D, Matas D, Almog N, Wolkowicz R, Goldfinger N, Pei H, Prokocimer M, Rotter V.
    Oncogene; 1998 Jun 25; 16(25):3269-77. PubMed ID: 9681825
    [Abstract] [Full Text] [Related]

  • 7. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
    Zhang HM, Yuan J, Cheung P, Chau D, Wong BW, McManus BM, Yang D.
    Mol Cell Biol; 2005 Jul 25; 25(14):6247-58. PubMed ID: 15988033
    [Abstract] [Full Text] [Related]

  • 8. DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.
    MacFarlane M, Jones NA, Dive C, Cohen GM.
    Mol Pharmacol; 1996 Oct 25; 50(4):900-11. PubMed ID: 8863836
    [Abstract] [Full Text] [Related]

  • 9. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.
    Willis A, Jung EJ, Wakefield T, Chen X.
    Oncogene; 2004 Mar 25; 23(13):2330-8. PubMed ID: 14743206
    [Abstract] [Full Text] [Related]

  • 10. Effects of wild-type and mutated p53 and Id proteins on the induction of apoptosis by adenovirus E1A, c-Myc, Bax, and Nip3 in p53 null mouse cerebellum cells.
    Tsunoda H, Terasawa T, Yageta M, Nakajima T, Tomooka Y, Tsuchida N, Oda K.
    Biochem Biophys Res Commun; 1999 Feb 24; 255(3):722-30. PubMed ID: 10049778
    [Abstract] [Full Text] [Related]

  • 11. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL, Ling YF, Lai MD.
    Anticancer Res; 2000 Feb 24; 20(1A):329-36. PubMed ID: 10769676
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT.
    Oncogene; 2002 May 09; 21(20):3149-61. PubMed ID: 12082630
    [Abstract] [Full Text] [Related]

  • 13. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
    Cinti C, Claudio PP, Luca AD, Cuccurese M, Howard CM, D'Esposito M, Paggi MG, Sala DL, Azzoni L, Halazonetis TD, Giordano A, Maraldi NM.
    Oncogene; 2000 Oct 19; 19(44):5098-105. PubMed ID: 11042698
    [Abstract] [Full Text] [Related]

  • 14. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P, Bazar K, Huper G, Lozano G, Marks J, Iglehart JD.
    Oncogene; 1996 Sep 19; 13(6):1315-22. PubMed ID: 8808706
    [Abstract] [Full Text] [Related]

  • 15. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
    Concin N, Stimpfl M, Zeillinger C, Wolff U, Hefler L, Sedlak J, Leodolter S, Zeillinger R.
    Int J Oncol; 2003 Jan 19; 22(1):51-7. PubMed ID: 12469184
    [Abstract] [Full Text] [Related]

  • 16. Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells.
    Itamochi H, Yamasaki F, Sudo T, Takahashi T, Bartholomeusz C, Das S, Terakawa N, Ueno NT.
    Cancer Gene Ther; 2006 May 19; 13(5):451-9. PubMed ID: 16294215
    [Abstract] [Full Text] [Related]

  • 17. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
    Konstantakou EG, Voutsinas GE, Karkoulis PK, Aravantinos G, Margaritis LH, Stravopodis DJ.
    Int J Oncol; 2009 Aug 19; 35(2):401-16. PubMed ID: 19578756
    [Abstract] [Full Text] [Related]

  • 18. Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death.
    Robles AI, Wang XW, Harris CC.
    Oncogene; 1999 Aug 19; 18(33):4681-8. PubMed ID: 10467415
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.